BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 32268083)

  • 1. FTO Demethylates Cyclin D1 mRNA and Controls Cell-Cycle Progression.
    Hirayama M; Wei FY; Chujo T; Oki S; Yakita M; Kobayashi D; Araki N; Takahashi N; Yoshida R; Nakayama H; Tomizawa K
    Cell Rep; 2020 Apr; 31(1):107464. PubMed ID: 32268083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTO regulates myoblast proliferation by controlling CCND1 expression in an m
    Deng K; Zhang Z; Ren C; Liang Y; Gao X; Fan Y; Wang F
    Exp Cell Res; 2021 Apr; 401(2):112524. PubMed ID: 33651996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTO demethylates regulates cell-cycle progression by controlling CCND1 expression in luteinizing goat granulosa cells.
    Li D; Zhou L; Liu Z; Zhang Z; Mao W; Shi W; Zhu M; Wang F; Wan Y
    Theriogenology; 2024 Mar; 216():20-29. PubMed ID: 38154203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m
    Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y
    Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells.
    Tsuruta N; Tsuchihashi K; Ohmura H; Yamaguchi K; Ito M; Ariyama H; Kusaba H; Akashi K; Baba E
    Biochem Biophys Res Commun; 2020 Sep; 530(1):235-239. PubMed ID: 32828292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m
    Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
    Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTO-Dependent
    Huang H; Wang Y; Kandpal M; Zhao G; Cardenas H; Ji Y; Chaparala A; Tanner EJ; Chen J; Davuluri RV; Matei D
    Cancer Res; 2020 Aug; 80(16):3200-3214. PubMed ID: 32606006
    [No Abstract]   [Full Text] [Related]  

  • 9. FTO regulates adipogenesis by controlling cell cycle progression via m
    Wu R; Liu Y; Yao Y; Zhao Y; Bi Z; Jiang Q; Liu Q; Cai M; Wang F; Wang Y; Wang X
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1323-1330. PubMed ID: 30305247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
    Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
    J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential m
    Wei J; Liu F; Lu Z; Fei Q; Ai Y; He PC; Shi H; Cui X; Su R; Klungland A; Jia G; Chen J; He C
    Mol Cell; 2018 Sep; 71(6):973-985.e5. PubMed ID: 30197295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4.
    Williamson EA; Burgess GS; Eder P; Litz-Jackson S; Boswell HS
    Leukemia; 1997 Jan; 11(1):73-85. PubMed ID: 9001421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPK regulates lipid accumulation in skeletal muscle cells through FTO-dependent demethylation of N
    Wu W; Feng J; Jiang D; Zhou X; Jiang Q; Cai M; Wang X; Shan T; Wang Y
    Sci Rep; 2017 Feb; 7():41606. PubMed ID: 28176824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m
    Sun K; Du Y; Hou Y; Zhao M; Li J; Du Y; Zhang L; Chen C; Yang H; Yan F; Su R
    Theranostics; 2021; 11(12):5831-5846. PubMed ID: 33897884
    [No Abstract]   [Full Text] [Related]  

  • 15. RNA demethylation by FTO stabilizes the FOXJ1 mRNA for proper motile ciliogenesis.
    Kim H; Lee YS; Kim SM; Jang S; Choi H; Lee JW; Kim TD; Kim VN
    Dev Cell; 2021 Apr; 56(8):1118-1130.e6. PubMed ID: 33761320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
    Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
    RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclin D1 overexpression on G1 progression-related events.
    Imoto M; Doki Y; Jiang W; Han EK; Weinstein IB
    Exp Cell Res; 1997 Oct; 236(1):173-80. PubMed ID: 9344597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle-independent induction of D1 and D2 cyclin expression, but not cyclin-Cdk complex formation or Rb phosphorylation, by IFNgamma in macrophages.
    Dey A; Li W
    Biochim Biophys Acta; 2000 Jun; 1497(1):135-47. PubMed ID: 10838167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m
    Wang X; Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Shi H; Wang F; Wang Y
    Autophagy; 2020 Jul; 16(7):1221-1235. PubMed ID: 31451060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADP modulates RNA m
    Wang L; Song C; Wang N; Li S; Liu Q; Sun Z; Wang K; Yu SC; Yang Q
    Nat Chem Biol; 2020 Dec; 16(12):1394-1402. PubMed ID: 32719557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.